Peter Heerma, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 6,116 shares at $24.77 ($151K) on 2021-10-04, disclosed to the SEC on 2021-10-05.
Open-market sale of $151k TVTX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.77 | 3,058 | $76K | 50.0% |
| 2 | $24.77 | 3,058 | $76K | 50.0% |
| Total | $24.77 avg | 6,116 | $151K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |